Special Report

10 Stocks That Will Win If Joe Biden Wins the Election

Cisco

This is a mega-cap tech leader for more conservative accounts to consider. Cisco Systems Inc. (NASDAQ: CSCO) designs, manufactures and sells internet protocol (IP) based networking products and services related to the communications and information technology industry worldwide.

It provides switching products, including fixed-configuration and modular switches, and storage products that provide connectivity to end users, workstations, IP phones, wireless access points and servers, as well as next-generation network routing products that interconnect public and private wireline and mobile networks for mobile, data, voice and video applications.

Cisco cybersecurity products give clients the scope, scale and capabilities to keep up with the complexity and volume of threats. Putting security above everything helps corporations innovate while keeping their assets safe.

Shareholders receive a 3.11% dividend. The consensus price objective is $49.19, and Cisco Systems stock closed at $46.26 on Tuesday.

Eastman Chemical

This stock has rallied smartly off the March lows and is another safe-haven for conservative accounts. Eastman Chemical Co. (NYSE: EMN) engages in the provision of specialty chemicals. It operates through the following segments.

The Additives and Functional Products segment includes chemicals for products in the transportation, consumables, building and construction, animal nutrition, crop protection, energy, personal and home care, and other markets. The Fiber segment offers cellulose acetate tow for use in filtration media, primarily cigarette filters.

The Advanced Materials segment of Eastman Chemical produces and markets its polymers, films and plastics with differentiated performance properties for value-added end uses in transportation, consumables, building and construction, durable goods, and health and wellness markets.

The Chemical Intermediates segment consists of large scale and vertical integration from the cellulose and acetyl, olefins and alkylamines streams to support operating segments with advantaged cost positions.

Eastman Chemical stock investors receive a 3.62% dividend. The $73.02 consensus target price compares with Tuesday’s close at $71.09.

Honeywell

This top industrial could be poised for a solid second half of 2020 if global growth picks up. Honeywell International Inc. (NYSE: HON) is a New Jersey-based, diversified, global technology and manufacturing company. Its operations are organized under four business groups: Aerospace, Home & Building Technologies, Safety & Productivity Solutions, and Performance Materials & Technologies.

The company is also a premier supplier of avionics, power and control systems for the aerospace industry. Last year, Jefferies analysts attended the company’s Honeywell Building Technologies Investor Showcase at the segment’s Atlanta headquarters and noted this:

HBT has improved its revenue and margin trajectory following the October 2018 spin-out of its residential business. This is being driven by management & cultural change (four of five segment leaders have been with the company for almost 2 years; President Vimal Kapur is new to HBT, coming from Honeywell’s Process Solutions segment last year). New leaders started reinvigorating products (rising vitality indexes across sub-segments).

Investors receive a 2.43% dividend. The posted consensus target is $159.15, and Honeywell International stock was last seen trading at $148.10.

Medtronic

This medical technology giant is a solid pick for investors looking for a safer position in the health care sector. Medtronic PLC (NYSE: MDT) develops, manufactures, distributes and sells device-based medical therapies to hospitals, physicians, clinicians and patients worldwide.

The company announced recently that Blackstone’s life sciences division will invest $337 million into the research and development of its diabetes device technologies. Under the terms of the agreement, Medtronic will receive funding for four diabetes programs over the next several years. Medtronic’s engineering, clinical and regulatory teams will conduct the development work for the programs.

Blackstone’s investment is sought to pull forward specific programs for its diabetes pump and continuous glucose monitoring pipeline devices that aim to address unmet patient needs. If the programs are successful, Medtronic will pay royalties that are expected to be in the low- to mid-single-digit range as a percentage of sales.

Investors receive a 2.45% dividend. The consensus price target is $110.17. Medtronic stock closed at $94.65.